RESPONSIBILITIES OF THE RESEARCH COMMITTEE Sample Clauses

RESPONSIBILITIES OF THE RESEARCH COMMITTEE. The Research Committee shall coordinate the activities carried out under the Research Program and monitor the progress of the Research Program. The Research Committee may revise or extend the Research Program as necessary to achieve the overall goal of discovering Active Compounds, developing Licensed Compounds, and commercializing Products; provided, however, that any such revision or extension shall be subject to agreement, if necessary, as to reimbursement of any additional costs. In particular, the Research Committee shall carry out the following responsibilities during the Research Term and the Tail End Period:
AutoNDA by SimpleDocs
RESPONSIBILITIES OF THE RESEARCH COMMITTEE. The Research Committee shall carry out the following responsibilities during the Research Term: (1) defining the yearly research and development objectives, (2) determining which Sumitomo or Tularik Substances or Tail End Compounds have shown sufficient activity in one or more Tularik Assay to be classified as a Program Compound, (3) selecting the Lead Compounds, (4) coordinating activities required to carry out the Program, (5) periodically revising the Program, (6) monitoring progress of the Program, (7) delegating responsibility for the filing and prosecution of Program Patents on inventions jointly discovered in the course of the Program, (8) coordinating activities required to carry out further development of Program Compounds, (9) allocating the [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. responsibilities for tasks and costs for preclinical studies, [ * ] utilized in both the Sumitomo Territory and Tularik Territory and (10) selecting the Preclinical Candidates.
RESPONSIBILITIES OF THE RESEARCH COMMITTEE. The Research Committee shall carry out the following responsibilities during the Research Term and, with respect to Option Compounds which continue to be subject to the Merck Option, for [ * ]: (1) defining the yearly research objectives, (2) determining whether a Program Substance has Anti-Viral Activity, [ * ]= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
RESPONSIBILITIES OF THE RESEARCH COMMITTEE. During the duration of the Collaborating Program, the Research Committee shall be the primary vehicle for interaction between the parties. The Research Committee shall serve at the behest of the parties in order to assist in the management of the Collaboration Program, recommend scientific priorities for both the Screening and Development Phases, and review and advise scientific direction and settlement of operating issues. Without limiting the foregoing, the Research Committee shall be responsible for: (i) amending research and development plans agreed to with respect to the Collaboration Program; (ii) monitoring the progress of the Collaboration Program; (iii) recommending work plans and budgets for each Joint Compound and Product, subject to both parties' approval, for the Development Phase; (iv) recommending whether patents should be filed; (v) evaluating the potential of Joint Compounds; (vi) advising which Candidates should become Joint Compounds; and (vii) preparing with the cooperation of both parties the progress reports described in Section 6.3. All decisions by the Research Committee shall require agreement by the senior representative of both parties present at the meeting, and each party shall act in good faith in attempting to reach agreement on such decisions. Any disputes shall be resolved in accordance with Article 10 of this Agreement.
RESPONSIBILITIES OF THE RESEARCH COMMITTEE. The Research Committee shall, among other things, (A) oversee the implementation and conduct of the Research Project, (B) determine if changes are needed to the Research Project or the time frames and budgeted FTE numbers and cost set forth in APPENDIX B, (C) approve and implement any changes to the Research Project or the time frames and budgeted FTE numbers and cost set forth in APPENDIX B and (D) facilitate on-going communications between the Parties. Any matter which requires a decision by, or the approval of, the Research Committee under this Agreement (including any matter described in APPENDIX A) shall require the affirmative consent of each representative of the Research Committee. At each meeting of the Research Committee, one EXECUTION COPY representative shall be appointed to record and distribute the minutes of such meeting.

Related to RESPONSIBILITIES OF THE RESEARCH COMMITTEE

  • Responsibilities of the Parties 7.1. Rostelecom and the User bear responsibility for non-fulfillment or improper fulfillment of their responsibilities in the Agreement in accordance with the current law of the Russian Federation, (including the Regulations) and the Agreement.

  • Responsibilities of Adviser Without limiting the generality of the foregoing, the Adviser shall, during the term and subject to the provisions of this Agreement:

  • Responsibilities of the Sponsor In connection with the issue and sale of the Preferred Securities, the Sponsor shall have the exclusive right and responsibility to engage in the following activities:

  • Development Responsibilities From and after the Effective Date, BMS shall assume sole responsibility for the Development of Compounds and Products in the Field in the Territory during the Term at its own cost and expense (including responsibility for all funding, resourcing and decision-making, subject to Sections 3.3 and 3.4), except with respect to the performance by Ambrx of the Research Program activities assigned to Ambrx pursuant to the Research Plan and as otherwise may be agreed upon by the Parties in writing. BMS, by itself or through its Affiliates and Sublicensees, shall use Diligent Efforts to Develop a Compound or Product in the Field in accordance with the Development Plan for the purpose of obtaining a Regulatory Approval in each Major Market. For clarity, it is understood and acknowledged that Diligent Efforts in the Development of Compounds and Products may include sequential implementation of Clinical Trials and/or intervals between Clinical Trials for data interpretation and clinical program planning and approval.

  • Delegation of Responsibilities The Advisor is authorized to delegate any or all of its rights, duties and obligations under this Agreement to one or more sub-advisors, and may enter into agreements with sub-advisors, and may replace any such sub-advisors from time to time in its discretion, in accordance with the 1940 Act, the Advisers Act, and rules and regulations thereunder, as such statutes, rules and regulations are amended from time to time or are interpreted from time to time by the staff of the Securities and Exchange Commission ("SEC"), and if applicable, exemptive orders or similar relief granted by the SEC and upon receipt of approval of such sub-advisors by the Board of Trustees and by shareholders (unless any such approval is not required by such statutes, rules, regulations, interpretations, orders or similar relief).

  • RESPONSIBILITY OF THE FUND With respect to each Loan held by the Custodian hereunder in accordance with the provisions hereof, the Fund shall (a) cause the Financing Documents evidencing such Loan to be delivered to the Custodian; (b) include with such Financing Documents an amortization schedule of payments (the “Payment Schedule”) identifying the amount and due dates of scheduled principal payments, the Interest Payable Date(s) and related payment amount information, and such other information with respect to the related Loan and Financing Documents as the Custodian reasonably may require in order to perform its services hereunder (collectively, “Loan Information”), in such form and format as the Custodian reasonably may require; (c) take, or cause the investment manager to take, all actions necessary to acquire good title to such Loan (or the participation in such Loan, as the case may be), as and to the extent intended to be acquired; and (d) cause the Custodian to be named as its nominee for payment purposes under the Financing Documents or otherwise provide for the direct payment of the Payments to the Custodian. The Custodian shall be entitled to rely upon the Loan Information provided to it by the Fund (or the investment manager acting on its behalf) without any obligation on the part of the Custodian independently to verify, investigate, recalculate, update or otherwise confirm the accuracy or completeness thereof; and the Custodian shall have no liability for any delay or failure on the part of the Fund in providing necessary Loan Information to the Custodian, or for any inaccuracy therein or incompleteness thereof. With respect to each such Loan, the Custodian shall be entitled to rely on any information and notices it may receive from time to time from the related bank agent, Obligor or similar party with respect to the related Loan, and shall be entitled to update its records on the basis of such information or notices received, without any obligation on its part independently to verify, investigate or recalculate such information.

  • Responsibilities of the Company 11.1 The Company agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further and other acts, documents, instruments and assurances as may reasonably be required by the Transfer Agent for the carrying out, or performing by the Transfer Agent of the provisions of this Agreement.

  • Activities of the Local Manager The services of the Local Manager to the Fund are not to be deemed to be exclusive, the Local Manager and any person controlled by or under common control with the Local Manager (for purposes of this Article V referred to as “affiliates”) being free to render services to others. It is understood that Directors, officers, employees and shareholders of the Fund are or may become interested in the Local Manager and its affiliates, as directors, officers, employees and shareholders or otherwise and that directors, officers, employees and shareholders of the Local Manager and its affiliates are or may become similarly interested in the Fund, and that the Local Manager and directors, officers, employees, partners and shareholders of its affiliates may become interested in the Fund as shareholders or otherwise.

  • Responsibilities of Sub-Adviser In carrying out its obligations under this Agreement, the Sub-Adviser agrees that it will:

  • Responsibilities of the Transfer Agent The Transfer Agent undertakes the duties and obligations imposed by this Agreement upon the following terms and conditions, by all of which the Fund, by its acceptance hereof, shall be bound:

Time is Money Join Law Insider Premium to draft better contracts faster.